# A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin

> **NCT04059588** · PHASE1 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 16 (actual)

## Conditions studied

- Cancer
- Solid Tumor
- Cancer of Skin

## Interventions

- **DRUG:** 2141 V-11

## Key facts

- **NCT ID:** NCT04059588
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-16
- **Primary completion:** 2023-03-13
- **Final completion:** 2023-03-13
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059588, "A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04059588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*